Exciting news for AutoScheduler.AI as they announce a successful funding round of $6.5 million! Recognized as a 2021 Gartner Cool Vendor for Supply Chain Execution, AutoScheduler is revolutionizing the way organizations manage their Warehouse Management Systems. With a focus on improving operational efficiency and addressing common challenges such as poor OTIF, dock schedule conflicts, and inefficient workforce allocation, AutoScheduler's innovative solution has already proven successful at some of the world's largest consumer goods companies. This latest injection of funds will enable AutoScheduler to further enhance its technology and expand its reach, helping even more organizations optimize their supply chain operations and streamline their logistics processes. The company is poised to continue its rapid growth and make a significant impact in the industry with this new round of funding.
AutoScheduler.AI Secures $6.5 Million in Funding to Revolutionize Warehouse Management Systems
Recently funded 路 $6.5MWMS Accelerator
Get the full AutoScheduler.AI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
